Trademark Overview
On Monday, December 8, 2025, a trademark application was filed for AGILERA with the United States Patent and Trademark Office. The USPTO has given the AGILERA trademark a serial number of 99536140. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Monday, April 20, 2026. This trademark is owned by Agilera Pharma AS. The AGILERA trademark is filed in the Pharmaceutical Products, Advertising, Business and Retail Services, Transportation & Storage Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Distributorship services in the field of radiopharmaceuticals; distributorship services featuring pharmaceuticals, radiopharmaceuticals, and nuclear medicine products; business management and logistics management in the field of radiopharmaceuticals; supply chain management for pharmaceutical and radiopharmaceutical products; business administration and consulting services for radiopharmaceutical and radiopharmacy operations; Regulatory submission management services, namely, assisting others in preparing and filing applications for radiopharmaceuticals with governmental regulatory bodies
isotope production for medical, research, and commercial use; contract development and manufacturing services (CDMO) in the field of pharmaceuticals and radiopharmaceuticals; Contract manufacturing in the field of pharmaceuticals; fill and finishing services, namely, clinical manufacturing of drug formulations for others to support clinical trials; Manufacturing services in the field of pharmaceuticals and radiopharmaceuticals; Custom manufacture of pharmaceuticals
laboratory testing, quality control, and validation services for radiopharmaceuticals; process development, optimization, and scale-up services; technological consultancy relating to radiopharmaceutical production and regulatory compliance; Pharmaceutical drug development services; Laboratory services for the production of radiopharmaceuticals in the nature of research and development of new products and testing of pharmaceuticals; Quality control for others; Scientific and technological services and research in the field of radiochemistry, radiopharmaceuticals, and nuclear medicine
Supply chain and logistics services, namely, transportation, delivery, distribution, and storage of radiopharmaceuticals and radioisotopes; consultation and coordination services relating to the transport and storage of radiopharmaceuticals and radioisotopes
Radiopharmaceutical and radioisotope preparations for clinical, medical, diagnostic and therapeutic use